SCHEMBL90831

SCHEMBL90831

CC(C)CCN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4271641 0.81
SCHEMBL406956 0.79
SCHEMBL7920598 0.77 LMNA (0.43)
SCHEMBL14197243 0.77 LMNA (0.43)
SCHEMBL26922174 0.77 LMNA (0.43)
SCHEMBL10035082 0.77 LMNA (0.43)
SCHEMBL5333588 0.77 LMNA (0.43)
SCHEMBL16207832 0.77 LMNA (0.43)
SCHEMBL2065444 0.77 LMNA (0.43)
SCHEMBL13977489 0.75 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115606-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2025-04-10 US disclosed
US-20240246962-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2024-07-25 US disclosed
US-11926626-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2024-03-12 US disclosed
US-20230398517-A1 NOVEL FORMO-PHENOLIC RESINS, PROCESS FOR THE PREPARATION THEREOF, AND USE OF SAME IN THE EXTRACTION OF URANIUM FROM WATER CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2023-12-14 US disclosed
CN-116406360-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2023-07-07 CN disclosed
EP-4204415-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2023-07-05 EP disclosed
US-20230107793-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-04-06 US disclosed
US-20230071840-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-03-09 US disclosed
WO-2022148442-A1 6-SUBSTITUTED PHOSPHORYL QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-07-14 WO disclosed
WO-2022042691-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-03-03 WO disclosed
US-20070264840-A1 Substrate Processing Apparatus and Method of Manufacturing Semiconductor Device HITACHI KOKUSAI ELECTRIC INC. (JP) 2007-11-15 US disclosed
US-7291257-B2 Two phase hydroprocessing PROCESS DYNAMICS, INC. (US) 2007-11-06 US disclosed
EP-1820442-A1 Noninvasive measurements of chemical substances Abreu, Marcio Marc Aurelio Martins (US) 2007-08-22 EP disclosed
EP-1808408-A2 Method and apparatus for producing products from natural gas Air Products and Chemicals, Inc. (US) 2007-07-18 EP disclosed
US-7238223-B2 Acoustical stimulation of vapor diffusion system and method BOARD OF THE REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-07-03 US disclosed
US-7232792-B2 3-heterocyclyl-substituted benzoyl derivatives BASF AKTIENGESELLSCHAFT (DE) 2007-06-19 US disclosed
US-7229693-B2 Low defect density, ideal oxygen precipitating silicon MEMC ELECTRONIC MATERIALS, INC. (US) 2007-06-12 US disclosed
US-20070128484-A1 Fuel cell system TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2007-06-07 US disclosed
US-7214578-B2 Method for fabricating semiconductor device MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2007-05-08 US disclosed
US-20020025910-A1 3-heterocycly1 - substituted benzoyl derivatives DEYN WOLFGANG VON (DE) 2002-02-28 US disclosed